-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, May 14th, can "Qingfei Paidu Decoction" reduce the risk of death from new coronary pneumonia? A large-scale multi-center clinical study conducted by Professor Li Jing's team from Fuwai Hospital of the Chinese Academy of Medical Sciences showed that "Qingfei Paidu Decoction" can reduce the risk of death in hospitalized patients with new coronary pneumonia by half.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
According to Li Jing, of the 8939 hospitalized patients with new coronary pneumonia included in this study, 29% received the "Qingfei Paidu Decoction" treatment.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
In order to ensure a reliable evaluation of the efficacy, the research team adopted the scientific method of "propensity score analysis" to make the main clinical characteristics of the treatment group and the control group basically consistent.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
With the special support of the new coronavirus pneumonia scientific research pilot project of the Chinese Academy of Medical Sciences' Medical and Health Science and Technology Innovation Project, the research team applied to the National Health Commission to carry out research on the new coronary pneumonia.
Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
Medical News, May 14th, can "Qingfei Paidu Decoction" reduce the risk of death from new coronary pneumonia? A large-scale multi-center clinical study conducted by Professor Li Jing's team from Fuwai Hospital of the Chinese Academy of Medical Sciences showed that "Qingfei Paidu Decoction" can reduce the risk of death in hospitalized patients with new coronary pneumonia by half.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
According to Li Jing, of the 8939 hospitalized patients with new coronary pneumonia included in this study, 29% received the "Qingfei Paidu Decoction" treatment.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
In order to ensure a reliable evaluation of the efficacy, the research team adopted the scientific method of "propensity score analysis" to make the main clinical characteristics of the treatment group and the control group basically consistent.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
With the special support of the new coronavirus pneumonia scientific research pilot project of the Chinese Academy of Medical Sciences' Medical and Health Science and Technology Innovation Project, the research team applied to the National Health Commission to carry out research on the new coronary pneumonia.
Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
Medical News, May 14th, can "Qingfei Paidu Decoction" reduce the risk of death from new coronary pneumonia? A large-scale multi-center clinical study conducted by Professor Li Jing's team from Fuwai Hospital of the Chinese Academy of Medical Sciences showed that "Qingfei Paidu Decoction" can reduce the risk of death in hospitalized patients with new coronary pneumonia by half.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
Relevant research results have been formally published in the international journal of plant pharmacology "Botany" recently.
According to Li Jing, of the 8939 hospitalized patients with new coronary pneumonia included in this study, 29% received the "Qingfei Paidu Decoction" treatment.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
The in-hospital mortality rate of patients who did not receive "Qingfei Paidu Decoction" was 4.
8%, and the mortality rate of patients who received "Qingfei Paidu Decoction" was 1.
2%.
In order to ensure a reliable evaluation of the efficacy, the research team adopted the scientific method of "propensity score analysis" to make the main clinical characteristics of the treatment group and the control group basically consistent.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
After excluding the effects of differences in clinical characteristics and other treatments between the two groups of patients, the risk of death for patients treated with "Qingfei Paidu Decoction" was half that of patients who did not receive "Qingfei Paidu Decoction" treatment.
With the special support of the new coronavirus pneumonia scientific research pilot project of the Chinese Academy of Medical Sciences' Medical and Health Science and Technology Innovation Project, the research team applied to the National Health Commission to carry out research on the new coronary pneumonia.
Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
Health health health hospital hospital hospital Once approved, the research team screened 558 new hospitals in the crown of pneumonia cases less than 100 cases of hospitalization and use the "clear lung soup detox" the number of cases of not less than 50 cases of hospital a total of 15, which are located in Hubei Province.
All hospitalized cases of new coronary pneumonia in these 15 hospitals from January to May 2020 were included in this study.
